Human monoclonal antibody therapy to prevent hepatitis C virus reinfection of liver transplants: advancing lead monoclonal antibodies into clinical trial

Project Information

HepaMAb

Grant agreement ID: 305600

Project closed

Start date 1 January 2013

End date 31 December 2017

Funded under

• Specific Programme "Cooperation": Health

Total cost € 7 825 522,59

EU contribution € 5 986 903,00

Coordinated by

THE UNIVERSITY OF NOTTINGHAM
United Kingdom